Results 71 to 80 of about 81,528 (247)
Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa
ABSTRACT Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl ...
Shiho Mori +2 more
wiley +1 more source
A Summary of the New International EAACI/GA2LEN/EDF/WAO Guidelines in Urticaria
Urticaria is a heterogeneous group of disorders, especially acute urticaria and angiooedema can be a medical emergency. This paper summarizes the EAACI/GA2LEN/EDF/WAO guidelines, the most recent international guidelines from 2009. Patients with urticaria
Torsten Zuberbier, MD
doaj +1 more source
Sleep Disturbance in Patients with Urticaria and Atopic Dermatitis: An Underestimated Burden
This study examined the relationship between insomnia and the frequent itching skin diseases, atopic dermatitis and chronic urticaria. Patients with chronic inflammatory dermatological diseases with pruritus were evaluated for insomnia (Insomnia Severity
C. Mann +3 more
semanticscholar +1 more source
Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos +2 more
wiley +1 more source
MRGPRX2 Activation Causes Increased Skin Reactivity in Chronic Spontaneous Urticaria Patients.
We present heightened skin reactivity in vivo to two MRGPRX2 drug ligands in patients with chronic spontaneous urticaria. Selectivity for the MRGPRX2 pathway by drug ligands was demonstrated by the loss of drug activation in MRGPRX2-KO LAD2 cells.
Maria Shtessel +6 more
semanticscholar +1 more source
Physiological changes during pregnancy can trigger or worsen dermatological conditions, yet evidence‐based guidance for safe management remains limited. In a cross‐sectional survey of 273 pregnant women, 33.7% reported having a skin disease, and 56% experienced worsening of symptoms.
Frederikke Seeberg +4 more
wiley +1 more source
FUNDAMENTOS: A urticária crônica compromete o doente por interferir nas atividades diárias, prejudicar a autoestima e as relações interpessoais. Os profissionais de saúde subestimam seu impacto na qualidade de vida dos doentes.
Ana Paula Fusel de Ue +5 more
doaj +1 more source
Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis
BackgroundDermatological illness can affect the quality of life and may coexist with psychiatric disorders.ObjectiveThe aim of this review was to systematically evaluate the published evidence of any psychiatric disorders that may coexist with chronic ...
G. Konstantinou, G. Konstantinou
semanticscholar +1 more source
Chronic inducible urticaria (CIndU) is a common inflammatory skin condition characterized by the recurrence of itchy wheals and/or angioedema that lasts more than 6 weeks and is induced by specific physical or environmental stimuli (cold, heat, exercise,
Iva Pozderac +5 more
semanticscholar +1 more source
ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang +9 more
wiley +1 more source

